Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors
Allison M. Weisnicht, Fernanda Szewc, Monica Moonkyung Cho, Han-Yun Hannah Cheng, Swetha Ganesh, Lauren Mahoney, Kathryn C. Fox, Portia R. Smith, Mallery R. Olsen, Rebecca M. Richards, David M. Vail, Christian M. Capitini
This study expands and activates allogeneic canine NK cells ex vivo, demonstrating their safety and in vitro potency for treating metastatic solid tumors.
bioRxiv · Mar 23, 2026 · PreprintCancer Biology